1. Copyright Notice
This presentation is copyrighted by the Psychopharmacology Institute.
Subscribers can download it and use it for professional use.
The contents of the presentation may be modified, but the Psychopharmacology Institute logo must remain visible in all slides.

2. Cardiovascular Effects of ADHD Drugs
Scott R. Beach, M.D.
Attending Psychiatrist, Massachusetts General Hospital
Assistant Professor of Psychiatry, Harvard Medical School

3. Stimulants
Recommendation against using stimulants in patients with serious cardiac problems 
No strong evidence for an association of stimulants with elevated risk of serious cardiac events
Schelleman, H., Bilker, W. B., Kimmel, S. E., Daniel, G. W., Newcomb, C., Guevara, J. P., ... & Hennessy, S. (2013). Amphetamines, atomoxetine and the risk of serious cardiovascular events in adults. PLoS One, 8(1), e52991.

4. Key Points
Stimulants tend to have cardiac effects that are generally not clinically significant.
The FDA continues to recommend against using stimulants in patients with serious cardiac problems.